South Africa In Vitro Diagnostics Market Outlook to 2018-Clinical Chemistry Genetic Testing, Haematology, Histologyand Cyt...
each of the segments and sub-segments within market categories. Data from 2004 to 2011,forecast forward for 7 years to 201...
4.4.2 Urine Analysis, Revenue (2004-2018) 424.5 Clinical Chemistry Distribution Share (2010-2011) 464.6 Clinical Chemistry...
9.1 Infectious Immunology, Market Segmentation 1339.2 Infectious Immunology Market, South Africa, Revenue Mix ($m), 2011 1...
11.11 Qiagen N.V. 16911.11.1 Company Overview 16911.12 Grifols, S.A. 16911.12.1 Company Overview 16911.13 Sysmex Corporati...
12.6 Histology And Cytology Market Pipeline Products 20212.7 Genetic Testing Market Pipeline Products 20313 Financial Deal...
23213.1.25 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor CellTechnology 23313.1.26 H...
Table 1: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 20Table 2: In Vitro Diagnostics...
Table 25: Haematology Reagents, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 69Table 26: Im...
Table 47: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 113Tab...
Table 69: Microbiology Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 157Table 70:...
Table 96: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus226Table 97: Immunexpress Enter...
2004-2011 34Figure 13: Clinical Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 36Figur...
Segment, Forecast, 2011-2018 80Figure 38: Haematology Cell Counters, South Africa, Revenue ($m) USD Constant, by Sub-Segme...
Figure 62: Immunochemistry Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 128Figu...
Upcoming SlideShare
Loading in …5
×

South Africa In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

143 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
143
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

South Africa In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

  1. 1. South Africa In Vitro Diagnostics Market Outlook to 2018-Clinical Chemistry Genetic Testing, Haematology, Histologyand Cytology, Immuno Chemistry, Infectious Immunology andMicrobiology CultureReport Details:Published:December 2012No. of Pages: 261Price: Single User License – US$2500South Africa In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing,Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology andMicrobiology CultureSummaryGlobalData’s new report, “South Africa In Vitro Diagnostics Market Outlook to 2018- ClinicalChemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, InfectiousImmunology and Microbiology Culture” provides key market data on the South Africa In VitroDiagnostics market. The report provides value (USD million), volume (units) and average price(USD) data for each segment and sub-segment within market categories – Immuno Chemistry,Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology, MicrobiologyCulture and Genetic Testing. The report also provides company shares and distribution sharesdata for each of the aforementioned market categories. The report is supplemented with globalcorporate-level profiles of the key market participants with information on company financials andpipeline products, wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for In Vitro Diagnostics market categories – ImmunoChemistry, Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology,Microbiology Culture and Genetic Testing.- Annualized market revenues (USD million), volume (units) and average price (USD) data for
  2. 2. each of the segments and sub-segments within market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the market categories.- Global corporate-level profiles of key companies operating within the South Africa In VitroDiagnostics market.- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, AbbottLaboratories, Beckman Coulter, Inc., bioMerieux S.A., Ortho-Clinical Diagnostics Inc. and others.Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the South Africa In VitroDiagnostics competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/213275-south-africa-in-vitro-diagnostics-market-outlook-to-2018-clinical-chemistry-genetic-testing-haematology-histology-and-cytology-immuno-chemistry-infectious-immunology-and-microbiology-culture.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 101.2 List of Figures 142 Introduction 172.1 What is This Report About? 173 In Vitro Diagnostics In South Africa 183.1 In Vitro Diagnostics, Market Segmentation 183.2 In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 193.3 In Vitro Diagnostics Market, South Africa, Revenue Mix ($m), 2011 213.4 In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2011 223.5 In Vitro Diagnostics, South Africa, Company Share (2010-2011) 294 Clinical Chemistry In South Africa 314.1 Clinical Chemistry, Market Segmentation 314.2 Clinical Chemistry Market, South Africa, Revenue Mix ($m), 2011 324.3 Clinical Chemistry Market, South Africa, Segment Contribution (%), 2011 334.4 Clinical Chemistry Overall Revenue, (2004-2018) 344.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 38
  3. 3. 4.4.2 Urine Analysis, Revenue (2004-2018) 424.5 Clinical Chemistry Distribution Share (2010-2011) 464.6 Clinical Chemistry, South Africa, Company Share (2010-2011) 475 Genetic Testing In South Africa 495.1 Genetic Testing, Market Segmentation 495.2 Genetic Testing Market, South Africa, Revenue Mix ($m), 2011 505.3 Genetic Testing Market, South Africa, Segment Contribution (%), 2011 515.4 Genetic Testing Overall Revenue, (2004-2018) 525.5 Genetic Testing Distribution Share (2010-2011) 565.6 Genetic Testing, South Africa, Company Share (2010-2011) 576 Haematology In South Africa 596.1 Haematology Market, Market Segmentation 596.2 Haematology Market, South Africa, Revenue Mix ($m), 2011 606.3 Haematology Market, South Africa, Segment Contribution (%), 2011 616.4 Haematology Overall Revenue, (2004-2018) 626.4.1 Haematology Reagents, Revenue (2004-2018) 666.4.2 Immunohaematology, Revenue (2004-2018) 706.4.3 Haemostasis, Revenue (2004-2018) 746.4.4 Haematology Rapid Tests, Revenue (2004-2018) 786.4.5 Haematology Cell Counters, Revenue (2004-2018) 826.5 Haematology Distribution Share (2010-2011) 866.6 Haematology, South Africa, Company Share (2010-2011) 877 Histology And Cytology In South Africa 897.1 Histology and Cytology Market, Market Segmentation 897.2 Histology And Cytology Market, South Africa, Revenue Mix ($m), 2011 907.3 Histology And Cytology Market, South Africa, Segment Contribution (%), 2011 917.4 Histology And Cytology Overall Revenue, (2004-2018) 927.5 Histology And Cytology Distribution Share (2010-2011) 967.6 Histology And Cytology, South Africa, Company Share (2010-2011) 978 Immuno Chemistry In South Africa 998.1 Immuno Chemistry Market, South Africa, Revenue Mix ($m), 2011 998.2 Immuno Chemistry Market, South Africa, Segment Contribution (%), 2011 1008.3 Immuno Chemistry Overall Revenue, (2004-2018) 1028.3.1 Disease Specific Immunochemistry, Revenue (2004-2018) 1068.3.2 Drugs of Abuse / Toxicology, Revenue (2004-2018) 1108.3.3 Endocrinology Tests, Revenue (2004-2018) 1148.3.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 1188.3.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 1228.3.6 Immunochemistry Analyzers, Revenue (2004-2018) 1268.4 Immuno Chemistry Distribution Share (2010-2011) 1308.5 Immuno Chemistry, South Africa, Company Share (2010-2011) 1319 Infectious Immunology In South Africa 133
  4. 4. 9.1 Infectious Immunology, Market Segmentation 1339.2 Infectious Immunology Market, South Africa, Revenue Mix ($m), 2011 1349.3 Infectious Immunology Market, South Africa, Segment Contribution (%), 2011 1359.4 Infectious Immunology Overall Revenue, (2004-2018) 1369.4.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 1409.5 Infectious Immunology Distribution Share (2010-2011) 1449.6 Infectious Immunology, South Africa, Company Share (2010-2011) 14510 Microbiology Culture In South Africa 14710.1 Microbiology Culture, Market Segmentation 14710.2 Microbiology Culture Market, South Africa, Revenue Mix ($m), 2011 14810.3 Microbiology Culture Market, South Africa, Segment Contribution (%), 2011 14910.4 Microbiology Culture Overall Revenue, (2004-2018) 15010.4.1 Microbiology Analyzers, Revenue (2004-2018) 15410.5 Microbiology Culture Distribution Share (2010-2011) 15810.6 Microbiology Culture, South Africa, Company Share (2010-2011) 15911 Overview of Key Companies in South Africa In Vitro Diagnostics Market 16111.1 F. Hoffmann-La Roche Ltd. 16111.1.1 Company Overview 16111.1.2 Share in the South Africa In Vitro Diagnostics Market 16111.2 Siemens Healthcare 16211.2.1 Company Overview 16211.2.2 Share in the South Africa In Vitro Diagnostics Market 16211.3 Abbott Laboratories 16311.3.1 Company Overview 16311.3.2 Share in the South Africa In Vitro Diagnostics Market 16311.4 Beckman Coulter, Inc. 16411.4.1 Company Overview 16411.4.2 Share in the South Africa In Vitro Diagnostics Market 16411.5 bioMerieux S.A. 16511.5.1 Company Overview 16511.5.2 Share in the South Africa In Vitro Diagnostics Market 16511.6 Ortho-Clinical Diagnostics Inc. 16611.6.1 Company Overview 16611.6.2 Share in the South Africa In Vitro Diagnostics Market 16611.7 Mindray Medical International Limited 16711.7.1 Company Overview 16711.8 Becton, Dickinson and Company 16711.8.1 Company Overview 16711.9 Alere Inc. 16811.9.1 Company Overview 16811.10 Bio-Rad Laboratories, Inc. 16811.10.1 Company Overview 168
  5. 5. 11.11 Qiagen N.V. 16911.11.1 Company Overview 16911.12 Grifols, S.A. 16911.12.1 Company Overview 16911.13 Sysmex Corporation 17011.13.1 Company Overview 17011.14 Horiba, Ltd. 17011.14.1 Company Overview 17011.15 Thermo Fisher Scientific Inc. 17111.15.1 Company Overview 17111.16 Trivitron Healthcare Pvt Ltd. 17111.16.1 Company Overview 17111.17 Gen-Probe Incorporated 17211.17.1 Company Overview 17211.18 DiaSorin S.p.A 17211.18.1 Company Overview 17211.19 Diagnostica Stago, Inc. 17311.19.1 Company Overview 17311.20 Phadia AB 17311.20.1 Company Overview 17311.21 Olympus Corporation 17311.21.1 Company Overview 17311.22 PerkinElmer, Inc. 17411.22.1 Company Overview 17411.23 Ani Labsystems Oy 17411.23.1 Company Overview 17411.24 Immucor, Inc. 17511.24.1 Company Overview 17511.25 Hologic, Inc. 17511.25.1 Company Overview 17511.26 Chembio Diagnostics, Inc. 17611.26.1 Company Overview 17611.27 Life Technologies Corporation 17611.27.1 Company Overview 17611.28 Danaher Corporation. 17711.28.1 Company Overview 17712 In Vitro Diagnostics Market Pipeline Products 17812.1 Clinical Chemisty Market Pipeline Products 17812.2 Immuno Chemistry Market Pipeline Products 18112.3 Haematology Market Pipeline Products 19212.4 Infectious Immunology Market Pipeline Products 19412.5 Microbiology Culture Market Pipeline Products 201
  6. 6. 12.6 Histology And Cytology Market Pipeline Products 20212.7 Genetic Testing Market Pipeline Products 20313 Financial Deals Landscape 20813.1 Partnerships 20813.1.1 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments ForArchimedes Particle Metrology System 20813.1.2 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 20913.1.3 BioDot Enters Into Co-Marketing Agreement With JOT Automation 21013.1.4 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New OncologyAssays 21113.1.5 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For DigitalMicroscopy Hematology Solutions 21213.1.6 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpressDx Test 21313.1.7 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology21413.1.8 Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 21513.1.9 CML HealthCare Enters Into Agreement With MaRS Innovation 21613.1.10 Castle Biosciences Enters Into Licensing Agreement With Brigham and Womens HospitalFor Mesothelioma Test 21713.1.11 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For ProteinArray Products 21813.1.12 GeneCentric Diagnostics Enters Into Licensing Agreement With University of NorthCarolina 21913.1.13 NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For OncotypeDX Tests 22013.1.14 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TBTest 22213.1.15 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich ForPhenoFluor 22313.1.16 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 22413.1.17 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 22513.1.18 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus22613.1.19 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 22713.1.20 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POCTest 22813.1.21 One Lambda Enters Into Co-Marketing Agreement With CellTrend 22913.1.22 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics ForALK Cancer Biomarker 23013.1.23 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 23113.1.24 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
  7. 7. 23213.1.25 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor CellTechnology 23313.1.26 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 23413.1.27 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRangePCR Kit 23513.1.28 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 23613.1.29 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery ForPressure Cycling Technology 23713.1.30 LipoScience Enters Into Licensing Agreement With Cleveland Clinic 23813.1.31 GE Healthcare Enters Into Co-Development Agreement With NXT2B For CompactCyclotron And PET Tracer System 23913.1.32 Sysmex Extends Distribution Agreement With Roche 24013.1.33 NexDx Enters Into Licensing Agreement With University of California For EpigeneticBiomarkers 24113.1.34 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 24214 Recent Developments 24314.1 Strategy And Business Planning 24314.1.1 Jul 24, 2012: Life Technologies And SATuRN Collaborate To Increase Access To HIVTesting In Africa 24314.2 Product News 24414.2.1 Oct 17, 2011: Signature Mapping Receives Order For TBDx Automated TuberculosisDiagnostic Systems 24414.2.2 Sep 14, 2011: Signature Mapping TBDx Tuberculosis Diagnostics Solution To Be DeployedIn Remote Intensive Case Finding Project 24514.2.3 Jan 11, 2010: HairDX Forms Alliance For Distribution Of HairDX Genetic Test In SouthAfrica 24515 Appendix 24615.1 Definitions of Markets Covered in the Report 24715.1.1 In Vitro Diagnostics 24715.2 Research Methodology 25815.3 Secondary Research 25815.4 Primary Research 25915.5 Models 25915.6 Forecasts 26015.7 Expert Panels 26015.8 GlobalData Consulting 26015.9 Currency Conversion 26115.10 Contact Us 26115.11 Disclaimer 2611.1 List of Tables
  8. 8. Table 1: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 20Table 2: In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2011 22Table 3: In Vitro Diagnostics Market, South Africa, Cross-Category Analysis, 2004-2018 24Table 4: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 26Table 5: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 28Table 6: In Vitro Diagnostics, South Africa, Company Share by Revenue ($m), USD Constant,2010-2011 30Table 7: Clinical Chemistry Market, South Africa, Segment Contribution (%), 2011 33Table 8: Clinical Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 35Table 9: Clinical Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 37Table 10: Clinical Chemisty Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 39Table 11: Clinical Chemisty Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 41Table 12: Urine Analysis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 43Table 13: Urine Analysis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 45Table 14: Clinical Chemistry, South Africa, Distribution Share by Revenue ($m), USD Constant,2010-2011 46Table 15: Clinical Chemistry, South Africa, Company Share by Revenue ($m), USD Constant,2010-2011 48Table 16: Genetic Testing Market, South Africa, Segment Contribution (%), 2011 51Table 17: Genetic Testing, South Africa, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 53Table 18: Genetic Testing, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 55Table 19: Genetic Testing, South Africa, Distribution Share by Revenue ($m), USD Constant,2010-2011 56Table 20: Genetic Testing, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 58Table 21: Haematology Market, South Africa, Segment Contribution (%), 2011 61Table 22: Haematology, South Africa, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 63Table 23: Haematology, South Africa, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 65Table 24: Haematology Reagents, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 67
  9. 9. Table 25: Haematology Reagents, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 69Table 26: Immunohaematology, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 71Table 27: Immunohaematology, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 73Table 28: Haemostasis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 75Table 29: Haemostasis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 77Table 30: Haematology Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 79Table 31: Haematology Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 81Table 32: Haematology Cell Counters, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 83Table 33: Haematology Cell Counters, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 85Table 34: Haematology, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 86Table 35: Haematology, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 88Table 36: Histology And Cytology Market, South Africa, Segment Contribution (%), 2011 91Table 37: Histology And Cytology, South Africa, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 93Table 38: Histology And Cytology, South Africa, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 95Table 39: Histology And Cytology, South Africa, Distribution Share by Revenue ($m), USDConstant, 2010-2011 96Table 40: Histology And Cytology, South Africa, Company Share by Revenue ($m), USDConstant, 2010-2011 98Table 41: Immuno Chemistry Market, South Africa, Segment Contribution (%), 2011 101Table 42: Immuno Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 103Table 43: Immuno Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 105Table 44: Disease Specific Immunochemistry, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 107Table 45: Disease Specific Immunochemistry, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 109Table 46: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 111
  10. 10. Table 47: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 113Table 48: Endocrinology Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 115Table 49: Endocrinology Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 117Table 50: Immunochemistry Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 119Table 51: Immunochemistry Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 121Table 52: Therapeutic Drug Monitoring, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 123Table 53: Therapeutic Drug Monitoring, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 125Table 54: Immunochemistry Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 127Table 55: Immunochemistry Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 129Table 56: Immuno Chemistry, South Africa, Distribution Share by Revenue ($m), USD Constant,2010-2011 130Table 57: Immuno Chemistry, South Africa, Company Share by Revenue ($m), USD Constant,2010-2011 132Table 58: Infectious Immunology Market, South Africa, Segment Contribution (%), 2011 135Table 59: Infectious Immunology, South Africa, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 137Table 60: Infectious Immunology, South Africa, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 139Table 61: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) USD Constant, bySub-Segment, Historic, 2004-2011 141Table 62: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) USD Constant, bySub-Segment, Forecast, 2011-2018 143Table 63: Infectious Immunology, South Africa, Distribution Share by Revenue ($m), USDConstant, 2010-2011 144Table 64: Infectious Immunology, South Africa, Company Share by Revenue ($m), USD Constant,2010-2011 146Table 65: Microbiology Culture Market, South Africa, Segment Contribution (%), 2011 149Table 66: Microbiology Culture, South Africa, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 151Table 67: Microbiology Culture, South Africa, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 153Table 68: Microbiology Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 155
  11. 11. Table 69: Microbiology Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 157Table 70: Microbiology Culture, South Africa, Distribution Share by Revenue ($m), USD Constant,2010-2011 158Table 71: Microbiology Culture, South Africa, Company Share by Revenue ($m), USD Constant,2010-2011 160Table 72: Clinical Chemisty Market Pipeline Products 178Table 73: Immuno Chemistry Market Pipeline Products 181Table 74: Haematology Market Pipeline Products 192Table 75: Infectious Immunology Market Pipeline Products 194Table 76: Microbiology Culture Market Pipeline Products 201Table 77: Histology And Cytology Market Pipeline Products 202Table 78: Genetic Testing Market Pipeline Products 203Table 79: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments ForArchimedes Particle Metrology System 208Table 80: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 209Table 81: BioDot Enters Into Co-Marketing Agreement With JOT Automation 210Table 82: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New OncologyAssays 211Table 83: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For DigitalMicroscopy Hematology Solutions 212Table 84: Med BioGene Amends Licensing Agreement With Precision Therapeutics ForLungExpress Dx Test 213Table 85: Ovizio Imaging Systems Enters Into Distribution Agreement With ApplikonBiotechnology 214Table 86: Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 215Table 87: CML HealthCare Enters Into Agreement With MaRS Innovation 216Table 88: Castle Biosciences Enters Into Licensing Agreement With Brigham and WomensHospital For Mesothelioma Test 217Table 89: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For ProteinArray Products 218Table 90: GeneCentric Diagnostics Enters Into Licensing Agreement With University of NorthCarolina 219Table 91: NewBridge Pharma Enters Into Licensing Agreement With Genomic Health ForOncotype DX Tests 220Table 92: Epistem Enters Into Distribution Agreement With Becton Dickinson For MycobacteriumTB Test 222Table 93: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich ForPhenoFluor 223Table 94: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 224Table 95: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test225
  12. 12. Table 96: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus226Table 97: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 227Table 98: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4POC Test 228Table 99: One Lambda Enters Into Co-Marketing Agreement With CellTrend 229Table 100: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight GeneticsFor ALK Cancer Biomarker 230Table 101: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 231Table 102: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERGMarker 232Table 103: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating TumorCell Technology 233Table 104: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 234Table 105: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen ForLongRange PCR Kit 235Table 106: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 236Table 107: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery ForPressure Cycling Technology 237Table 108: LipoScience Enters Into Licensing Agreement With Cleveland Clinic 238Table 109: GE Healthcare Enters Into Co-Development Agreement With NXT2B For CompactCyclotron And PET Tracer System 239Table 110: Sysmex Extends Distribution Agreement With Roche 240Table 111: NexDx Enters Into Licensing Agreement With University of California For EpigeneticBiomarkers 241Table 112: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 2421.2 List of FiguresFigure 1: In Vitro Diagnostics, Market Segmentation 18Figure 2: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 19Figure 3: In Vitro Diagnostics Market, South Africa, Revenue Mix ($m), 2011 21Figure 4: In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2011 22Figure 5: In Vitro Diagnostics Market, South Africa, Cross-Category Analysis, 2004-2018 23Figure 6: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25Figure 7: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Forecast,2011-2018 27Figure 8: In Vitro Diagnostics, South Africa, Company Share (%), 2011 29Figure 9: Clinical Chemistry, Market Segmentation 31Figure 10: Clinical Chemistry Market, South Africa, Revenue Mix ($m), 2011 32Figure 11: Clinical Chemistry Market, South Africa, Segment Contribution (%), 2011 33Figure 12: Clinical Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Historic,
  13. 13. 2004-2011 34Figure 13: Clinical Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 36Figure 14: Clinical Chemisty Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 38Figure 15: Clinical Chemisty Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 40Figure 16: Urine Analysis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 42Figure 17: Urine Analysis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 44Figure 18: Clinical Chemistry, South Africa, Company Share (%), 2011 47Figure 19: Genetic Testing, Market Segmentation 49Figure 20: Genetic Testing Market, South Africa, Revenue Mix ($m), 2011 50Figure 21: Genetic Testing Market, South Africa, Segment Contribution (%), 2011 51Figure 22: Genetic Testing, South Africa, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 52Figure 23: Genetic Testing, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 54Figure 24: Genetic Testing, South Africa, Company Share (%), 2011 57Figure 25: Haematology Market, Market Segmentation 59Figure 26: Haematology Market, South Africa, Revenue Mix ($m), 2011 60Figure 27: Haematology Market, South Africa, Segment Contribution (%), 2011 61Figure 28: Haematology, South Africa, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 62Figure 29: Haematology, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 64Figure 30: Haematology Reagents, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 66Figure 31: Haematology Reagents, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 68Figure 32: Immunohaematology, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 70Figure 33: Immunohaematology, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 72Figure 34: Haemostasis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 74Figure 35: Haemostasis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 76Figure 36: Haematology Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 78Figure 37: Haematology Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-
  14. 14. Segment, Forecast, 2011-2018 80Figure 38: Haematology Cell Counters, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 82Figure 39: Haematology Cell Counters, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 84Figure 40: Haematology, South Africa, Company Share (%), 2011 87Figure 41: Histology and Cytology Market, Market Segmentation 89Figure 42: Histology And Cytology Market, South Africa, Revenue Mix ($m), 2011 90Figure 43: Histology And Cytology Market, South Africa, Segment Contribution (%), 2011 91Figure 44: Histology And Cytology, South Africa, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 92Figure 45: Histology And Cytology, South Africa, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 94Figure 46: Histology And Cytology, South Africa, Company Share (%), 2011 97Figure 47: Immuno Chemistry Market, South Africa, Revenue Mix ($m), 2011 99Figure 48: Immuno Chemistry Market, South Africa, Segment Contribution (%), 2011 100Figure 49: Immuno Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 102Figure 50: Immuno Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 104Figure 51: Disease Specific Immunochemistry, South Africa, Revenue ($m) USD Constant, bySub-Segment, Historic, 2004-2011 106Figure 52: Disease Specific Immunochemistry, South Africa, Revenue ($m) USD Constant, bySub-Segment, Forecast, 2011-2018 108Figure 53: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 110Figure 54: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 112Figure 55: Endocrinology Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 114Figure 56: Endocrinology Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 116Figure 57: Immunochemistry Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 118Figure 58: Immunochemistry Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 120Figure 59: Therapeutic Drug Monitoring, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 122Figure 60: Therapeutic Drug Monitoring, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 124Figure 61: Immunochemistry Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 126
  15. 15. Figure 62: Immunochemistry Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 128Figure 63: Immuno Chemistry, South Africa, Company Share (%), 2011 131Figure 64: Infectious Immunology, Market Segmentation 133Figure 65: Infectious Immunology Market, South Africa, Revenue Mix ($m), 2011 134Figure 66: Infectious Immunology Market, South Africa, Segment Contribution (%), 2011 135Figure 67: Infectious Immunology, South Africa, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 136Figure 68: Infectious Immunology, South Africa, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 138Figure 69: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) USD Constant, bySub-Segment, Historic, 2004-2011 140Figure 70: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) USD Constant, bySub-Segment, Forecast, 2011-2018 142Figure 71: Infectious Immunology, South Africa, Company Share (%), 2011 145Figure 72: Microbiology Culture, Market Segmentation 147Figure 73: Microbiology Culture Market, South Africa, Revenue Mix ($m), 2011 148Figure 74: Microbiology Culture Market, South Africa, Segment Contribution (%), 2011 149Figure 75: Microbiology Culture, South Africa, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 150Figure 76: Microbiology Culture, South Africa, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 152Figure 77: Microbiology Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 154Figure 78: Microbiology Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 156Figure 79: Microbiology Culture, South Africa, Company Share (%), 2011 159Figure 80: F. Hoffmann-La Roche Ltd., Company Share (%),South Africa In Vitro DiagnosticsMarket, 2011 161Figure 81: Siemens Healthcare, Company Share (%),South Africa In Vitro Diagnostics Market,2011 162Figure 82: Abbott Laboratories, Company Share (%),South Africa In Vitro Diagnostics Market,2011 163Figure 83: Danaher Corporation, Company Share (%),South Africa In Vitro Diagnostics Market,2011 164Figure 84: bioMerieux S.A., Company Share (%),South Africa In Vitro Diagnostics Market, 2011165Figure 85: Ortho-Clinical Diagnostics Inc., Company Share (%),South Africa In Vitro DiagnosticsMarket, 2011 166Contact: sales@reportsandreports.com for more information.

×